High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients

Overview of attention for article published in Molecular Cancer, February 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MACC1-INHIBITOR FOR TARGETED THERAPY OF MACC1-INDUCED METASTASIS

Application WO-2022223664-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS AND METHODS FOR PROGNOSING AND TREATING COLORECTAL CANCER

Application WO-2018091419-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.